The Vox Markets Podcast
/
Jonathan Tobin, MD of Arix Bioscience discusses one of their portfolio companies, Artios Pharma, that's announced global strategic collaboration with Merck worth $7bn
Our original embed player - you can use this to maintain continuity with any other episodes you've already embedded. Otherwise we'd suggest
upgrading to our new player.